Professor Danny Eckert, Director at the Adelaide Institute for Sleep Health: Flinders Health and Medical Research Institute Sleep Health Research Program, says his research team has examined ...

The findings of a new study presented at ESMO may offer a new treatment for non–small cell lung cancer. The combination of immunotherapy agents nivolumab (Opdivo) and low-dose ipilimumab (Yervoy) ...

This episode, titled 'What It Takes to Make the Pathway: Clinical and Operational Criteria for Adding New Combinations in RRFL,' features Ryan Haumschild, PharmD, MS, MBA, CPEL discussing the ...

In the current era of multiple therapies for pulmonary arterial hypertension (PAH), the use of combination therapy is becoming common. The REVEAL registry demonstrated that nearly 50% of patients with ...